Why the study?
Although aging enhances atherosclerosis, it was unknown whether this occurs via alterations in circulating immune cells, lipid metabolism, vasculature, or adipose tissue.
Does transplantation of aged visceral fat increase atherosclerosis in Ldlr -/- mice compared to young visceral fat?
Does transplantation of aged visceral fat increase atherosclerosis in Ldlr -/- mice compared to young visceral fat?
Effect estimate: >3-fold increase
Aging enhances atherosclerosis via increased inflammation of visceral fat, suggesting that targeting visceral fat inflammation may reduce atherosclerotic disease burden in older populations.
Does not support clinical translation; leaves open whether targeting aged visceral fat inflammation mitigates atherosclerosis in humans.
Although aging enhances atherosclerosis, we do not know if this occurs via alterations in circulating immune cells, lipid metabolism, vasculature, or adipose tissue. Here, we examined whether aging exerts a direct pro‐atherogenic effect on adipose tissue in mice. After demonstrating that aging augmented the inflammatory profile of visceral but not subcutaneous adipose tissue, we transplanted visceral fat from young or aged mice onto the right carotid artery of Ldlr −/− recipients. Aged fat transplants not only increased atherosclerotic plaque size with increased macrophage numbers in the adjacent carotid artery, but also in distal vascular territories, indicating that aging of the adipose tissue enhances atherosclerosis via secreted factors. By depleting macrophages from the visceral fat, we identified that adipose tissue macrophages are major contributors of the secreted factors. To identify these inflammatory factors, we found that aged fat transplants secreted increased levels of the inflammatory mediators TNFα, CXCL2, and CCL2, which synergized to promote monocyte chemotaxis. Importantly, the combined blockade of these inflammatory mediators impeded the ability of aged fat transplants to enhance atherosclerosis. In conclusion, our study reveals that aging enhances atherosclerosis via increased inflammation of visceral fat. Our study suggests that future therapies targeting the visceral fat may reduce atherosclerosis disease burden in the expanding older population.
No takes yet. Share an insight, caveat, or question.
Song et al. (2023) studied Atherosclerosis. Aged visceral fat transplantation vs. Young visceral fat transplantation or sham surgery was evaluated on Atherosclerotic lesion size in the right carotid artery (>3-fold increase).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: